Arpelos Biosciences
Cambridge, United States · Founded 2021 · $9.5M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- arpelos.com
- Total Funding
- $9.5M
- Last Round
- $9.5M Seed
- Rounds
- 1
About
Develops multivalent biologic therapeutics to achieve high potency and selectivity for targeted disease treatments.
Summary
Arpelos Biosciences is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $9.5M in total across 1 round.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.